Archives
-
EZ Cap EGFP mRNA 5-moUTP: Evidence & Workflow
2026-09-07
EZ Cap EGFP mRNA 5-moUTP is an enhanced green fluorescent protein mRNA reporter with a Cap 1 structure, 5-methoxyuridine modification, and an approximately 100-nucleotide poly(A) tail. Its defined formulation supports mRNA delivery for gene expression, translation efficiency assay design, and fluorescence-based imaging while requiring separate validation of delivery and immune-response variables.
-
Haloprogin: Workflows for Antifungal Research
2026-09-07
Haloprogin supports reproducible studies spanning dermatophytes, Candida, and selected Gram-positive bacteria, with practical benchmarks for MIC, MFC, and topical infection models. This guide translates foundational evidence into assay-ready workflows, formulation choices, and troubleshooting strategies for preclinical antimicrobial research.
-
Mn²⁺-Enriched mRNA Nanoparticles for Better Vaccines
2026-09-05
The reference study introduces a manganese-mediated strategy that condenses mRNA into a high-density core before lipid coating, addressing the limited RNA loading and lipid burden of conventional LNP vaccines. In the reported experiments, L@Mn-mRNA nearly doubled mRNA loading and increased cellular uptake about twofold, providing a mechanistic basis for stronger vaccine responses; see the reference study.
-
SM-102 for Practical mRNA Delivery Workflows
2026-09-04
SM-102 supports reproducible lipid nanoparticle workflows for mRNA delivery, from ethanol-based lipid preparation to reporter and therapeutic payload testing. Its value extends beyond mRNA vaccine development: the localized p21 mRNA study illustrates how an SM-102-containing formulation could be evaluated for tissue-directed oncology applications without assuming that vaccine and intravesical formulations are interchangeable.
-
D-Luciferin: From Signal to Mechanism
2026-09-04
D-Luciferin potassium salt can do more than produce a bioluminescent signal: it can support carefully designed experiments that connect promoter regulation with functional biology. This article uses the OfMYB1R114–OfSDIR1-like–OfCCD4 study to explain assay logic, controls, and practical limitations.
-
Tunable Human Intestinal Organoids: Study Insights
2026-09-03
Yang and colleagues developed a human small intestinal organoid system that strengthens stemness while preserving broad differentiation, avoiding the usual trade-off between expansion and cellular diversity. Their tunable framework enables reversible or directional shifts in intestinal cell fate and may improve organoid scalability for disease modeling and high-throughput studies.
-
Microplastics, Nanoplastics, and Pulmonary Fibrosis
2026-09-03
A comparative Toxicology study tested polystyrene, polyethylene, and polypropylene particles at microplastic and nanoplastic scales in mice and BEAS-2B lung epithelial cells. Its findings indicate that polymer identity and particle size shape pulmonary fibrotic responses, with polystyrene nanoplastics producing the strongest effects and implicating dysregulated FXR–YAP1 signaling.
-
Sulfo-Cy5 NHS Ester in Immune Imaging
2026-09-02
A translational framework for using Sulfo-Cy5 NHS ester to distinguish immune-cell localization from mechanism in studies of metal-ion-chelating L-phenylalanine nanostructures and checkpoint blockade.
-
Isradipine (Dynacirc): From L-Type Biology to Translation
2026-09-02
Isradipine (Dynacirc) is more than a calcium channel blocker for hypertension research: it is a mechanistically useful probe for connecting L-type calcium influx with vascular function, neuronal calcium stress, and translational study design.
-
MERS-CoV RBD-mRNA: Immunogenicity and Protection
2026-09-01
The 2025 Cells study provides a direct comparison of MERS-CoV spike- and receptor-binding domain mRNAs in the same lipid nanoparticle platform, finding that RBD-mRNA generated stronger, broader, and more durable neutralizing responses. In mice, this response was associated with durable protection against viral challenge, supporting RBD-focused antigen design while leaving important questions about dose, formulation, and clinical translation unresolved.
-
ARCA EGFP mRNA for Reliable Transfection Workflows
2026-09-01
ARCA EGFP mRNA provides a fast, direct fluorescence readout for separating delivery problems from downstream protein-expression variability. Use it to benchmark lipid nanoparticles, optimize mammalian cell transfection, and troubleshoot reporter or therapeutic mRNA workflows before committing to costly biological endpoints.
-
GSK 2837808A: LDHA Inhibition Workflows
2026-08-31
Use GSK 2837808A to separate LDHA-dependent lactate production from broader glycolytic effects in cancer-cell assays. This guide combines validated hepatocellular carcinoma applications with hypothesis-driven workflows for testing the NAT1–ENO1–lactate axis in colorectal cancer.
-
Cy7 NHS Ester: Practical Labeling Guide
2026-08-31
Cy7 NHS ester (SKU A8109) is a water-soluble amino-reactive near-infrared dye for labeling proteins and peptides while minimizing the need for organic co-solvents. It is suited to near-infrared fluorescent imaging and biomolecule conjugation, but prepared solutions should be used promptly and the reagent is not appropriate for targets lacking accessible primary amines.
-
EZ Cap™ Firefly Luciferase mRNA Guide
2026-08-30
EZ Cap™ Firefly Luciferase mRNA is an IVT reporter transcript with a Cap1 analog and optimized poly(A) tail for sustained luciferase expression. It supports mRNA delivery and translation efficiency assay workflows, gene regulation reporter assays, and in vivo bioluminescence imaging.
-
CAY10499: A Precision Tool for Lipid Flux
2026-08-29
CAY10499, an inhibitor of human hormone sensitive lipase, enables mechanistic separation of lipid hydrolysis from ACLY-driven lipid synthesis. This article presents a practical framework for applying the compound to enzyme, immunometabolic, steroidogenesis, and atherosclerosis research without overstating evidence from tumor models.